Literature DB >> 15463518

Reinfection, exposure and immunity in human schistosomiasis.

P Hagan1.   

Abstract

In this review Paul Hagan will focus on the results of the reinfection studies that have been completed on Schistosoma mansoni in Kenya and Brazil and on S. haematobium in The Gambia. The review will also draw on the data from other immunological, molecular and epidemiological studies that have provided information that may be relevant to an understanding of immunity in human schistosomiasis. No attempt will be made to describe the latest advances that have been reported from studies of the animal models of schistosomiasis; these are adequately dealt with elsewhere.

Entities:  

Year:  1992        PMID: 15463518     DOI: 10.1016/0169-4758(92)90303-j

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  10 in total

1.  The contribution of water contact behavior to the high Schistosoma mansoni Infection rates observed in the Senegal River Basin.

Authors:  Seydou Sow; Sake J de Vlas; Foekje Stelma; Kim Vereecken; Bruno Gryseels; Katja Polman
Journal:  BMC Infect Dis       Date:  2011-07-18       Impact factor: 3.090

2.  Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.

Authors:  Takafira Mduluza; Francisca Mutapi; Tinashe Ruwona; Daniel Kaluka; Nicholas Midzi; Patricia D Ndhlovu
Journal:  Malawi Med J       Date:  2009-12       Impact factor: 0.875

Review 3.  Schistosomiasis vaccines.

Authors:  Afzal A Siddiqui; Bilal A Siddiqui; Lisa Ganley-Leal
Journal:  Hum Vaccin       Date:  2011-11-01

4.  Ascaris reinfection of slum children: relation with the IgE response.

Authors:  I Hagel; N R Lynch; M C Di Prisco; E Rojas; M Pérez; N Alvarez
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

5.  Herd immunity to filarial infection is a function of vector biting rate.

Authors:  E Michael; D A Bundy
Journal:  Proc Biol Sci       Date:  1998-05-22       Impact factor: 5.349

6.  Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons.

Authors:  M Nyindo; T M Kariuki; P W Mola; I O Farah; L Elson; R E Blanton; C L King
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

Review 7.  Experimental vaccines in animal models for schistosomiasis.

Authors:  Afzal A Siddiqui; Gul Ahmad; Raymond T Damian; Ronald C Kennedy
Journal:  Parasitol Res       Date:  2008-02-08       Impact factor: 2.289

Review 8.  Concomitant Immunity and Worm Senescence May Drive Schistosomiasis Epidemiological Patterns: An Eco-Evolutionary Perspective.

Authors:  Julia C Buck; Giulio A De Leo; Susanne H Sokolow
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

Review 9.  Reassessing therapeutic antibodies for neglected and tropical diseases.

Authors:  Rob Hooft van Huijsduijnen; Somei Kojima; Dee Carter; Hisafumi Okabe; Akihide Sato; Wataru Akahata; Timothy N C Wells; Kei Katsuno
Journal:  PLoS Negl Trop Dis       Date:  2020-01-30

10.  Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.

Authors:  Claire D Bourke; Norman Nausch; Nadine Rujeni; Laura J Appleby; Kate M Mitchell; Nicholas Midzi; Takafira Mduluza; Francisca Mutapi
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.